Logo image of BILL

BILL HOLDINGS INC (BILL) Stock Fundamental Analysis

USA - NYSE:BILL - US0900431000 - Common Stock

52.59 USD
+0.65 (+1.25%)
Last: 9/18/2025, 8:04:00 PM
52.59 USD
0 (0%)
After Hours: 9/18/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BILL. BILL was compared to 280 industry peers in the Software industry. BILL has a medium profitability rating, but doesn't score so well on its financial health evaluation. BILL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BILL was profitable.
BILL had a positive operating cash flow in the past year.
In the past 5 years BILL reported 4 times negative net income.
BILL had a positive operating cash flow in 4 of the past 5 years.
BILL Yearly Net Income VS EBIT VS OCF VS FCFBILL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.24%, BILL is in the better half of the industry, outperforming 60.36% of the companies in the same industry.
BILL has a Return On Equity of 0.61%. This is in the better half of the industry: BILL outperforms 62.86% of its industry peers.
Industry RankSector Rank
ROA 0.24%
ROE 0.61%
ROIC N/A
ROA(3y)-0.8%
ROA(5y)-1.52%
ROE(3y)-1.86%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
BILL Yearly ROA, ROE, ROICBILL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8

1.3 Margins

Looking at the Profit Margin, with a value of 1.63%, BILL is in the better half of the industry, outperforming 63.57% of the companies in the same industry.
BILL has a Gross Margin of 81.40%. This is amongst the best in the industry. BILL outperforms 85.00% of its industry peers.
In the last couple of years the Gross Margin of BILL has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 1.63%
GM 81.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y1.61%
BILL Yearly Profit, Operating, Gross MarginsBILL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

BILL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BILL has less shares outstanding
BILL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BILL has a worse debt to assets ratio.
BILL Yearly Shares OutstandingBILL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BILL Yearly Total Debt VS Total AssetsBILL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

BILL has an Altman-Z score of 0.75. This is a bad value and indicates that BILL is not financially healthy and even has some risk of bankruptcy.
BILL's Altman-Z score of 0.75 is on the low side compared to the rest of the industry. BILL is outperformed by 66.79% of its industry peers.
The Debt to FCF ratio of BILL is 5.54, which is a neutral value as it means it would take BILL, 5.54 years of fcf income to pay off all of its debts.
BILL has a Debt to FCF ratio (5.54) which is in line with its industry peers.
A Debt/Equity ratio of 0.43 indicates that BILL is not too dependend on debt financing.
The Debt to Equity ratio of BILL (0.43) is worse than 62.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.54
Altman-Z 0.75
ROIC/WACCN/A
WACC10.09%
BILL Yearly LT Debt VS Equity VS FCFBILL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

BILL has a Current Ratio of 1.58. This is a normal value and indicates that BILL is financially healthy and should not expect problems in meeting its short term obligations.
BILL has a Current ratio (1.58) which is in line with its industry peers.
BILL has a Quick Ratio of 1.58. This is a normal value and indicates that BILL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.58, BILL is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
BILL Yearly Current Assets VS Current LiabilitesBILL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for BILL have decreased by -5.13% in the last year.
The Revenue has grown by 13.36% in the past year. This is quite good.
The Revenue has been growing by 56.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-5.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.02%
Revenue 1Y (TTM)13.36%
Revenue growth 3Y31.58%
Revenue growth 5Y56.14%
Sales Q2Q%11.55%

3.2 Future

BILL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.93% yearly.
The Revenue is expected to grow by 12.67% on average over the next years. This is quite good.
EPS Next Y0.07%
EPS Next 2Y9.89%
EPS Next 3Y9.19%
EPS Next 5Y19.93%
Revenue Next Year10.78%
Revenue Next 2Y12.22%
Revenue Next 3Y13.54%
Revenue Next 5Y12.67%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BILL Yearly Revenue VS EstimatesBILL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
BILL Yearly EPS VS EstimatesBILL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

BILL is valuated rather expensively with a Price/Earnings ratio of 23.69.
BILL's Price/Earnings ratio is a bit cheaper when compared to the industry. BILL is cheaper than 72.86% of the companies in the same industry.
When comparing the Price/Earnings ratio of BILL to the average of the S&P500 Index (27.41), we can say BILL is valued inline with the index average.
With a Price/Forward Earnings ratio of 23.67, BILL is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BILL indicates a somewhat cheap valuation: BILL is cheaper than 70.71% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BILL to the average of the S&P500 Index (22.88), we can say BILL is valued inline with the index average.
Industry RankSector Rank
PE 23.69
Fwd PE 23.67
BILL Price Earnings VS Forward Price EarningsBILL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BILL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, BILL is valued cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.26
EV/EBITDA 393.74
BILL Per share dataBILL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BILL does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)337.12
PEG (5Y)N/A
EPS Next 2Y9.89%
EPS Next 3Y9.19%

0

5. Dividend

5.1 Amount

No dividends for BILL!.
Industry RankSector Rank
Dividend Yield N/A

BILL HOLDINGS INC

NYSE:BILL (9/18/2025, 8:04:00 PM)

After market: 52.59 0 (0%)

52.59

+0.65 (+1.25%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners91.8%
Inst Owner Change-6.98%
Ins Owners3.28%
Ins Owner Change4.56%
Market Cap5.34B
Analysts74.84
Price Target59.49 (13.12%)
Short Float %11.03%
Short Ratio2.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.04%
Min EPS beat(2)28.01%
Max EPS beat(2)30.07%
EPS beat(4)4
Avg EPS beat(4)25.06%
Min EPS beat(4)19.52%
Max EPS beat(4)30.07%
EPS beat(8)8
Avg EPS beat(8)23.94%
EPS beat(12)12
Avg EPS beat(12)56.68%
EPS beat(16)16
Avg EPS beat(16)58.54%
Revenue beat(2)0
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)0.73%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)9
Avg Revenue beat(12)2.69%
Revenue beat(16)13
Avg Revenue beat(16)4.44%
PT rev (1m)-3.03%
PT rev (3m)-8.04%
EPS NQ rev (1m)-8.61%
EPS NQ rev (3m)-6.59%
EPS NY rev (1m)0.14%
EPS NY rev (3m)1.67%
Revenue NQ rev (1m)-0.97%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)-1.56%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 23.69
Fwd PE 23.67
P/S 3.65
P/FCF 17.26
P/OCF 15.24
P/B 1.37
P/tB 4.13
EV/EBITDA 393.74
EPS(TTM)2.22
EY4.22%
EPS(NY)2.22
Fwd EY4.22%
FCF(TTM)3.05
FCFY5.79%
OCF(TTM)3.45
OCFY6.56%
SpS14.39
BVpS38.51
TBVpS12.74
PEG (NY)337.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.24%
ROE 0.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.63%
GM 81.4%
FCFM 21.17%
ROA(3y)-0.8%
ROA(5y)-1.52%
ROE(3y)-1.86%
ROE(5y)-3.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y1.61%
F-Score7
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 5.54
Debt/EBITDA 190.16
Cap/Depr 45.81%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion 3966.56%
Profit Quality 1301.21%
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 0.75
F-Score7
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)32.89%
Cap/Depr(5y)61.93%
Cap/Sales(3y)2.46%
Cap/Sales(5y)3.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.02%
EPS Next Y0.07%
EPS Next 2Y9.89%
EPS Next 3Y9.19%
EPS Next 5Y19.93%
Revenue 1Y (TTM)13.36%
Revenue growth 3Y31.58%
Revenue growth 5Y56.14%
Sales Q2Q%11.55%
Revenue Next Year10.78%
Revenue Next 2Y12.22%
Revenue Next 3Y13.54%
Revenue Next 5Y12.67%
EBIT growth 1Y45.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.74%
EBIT Next 3Y21.49%
EBIT Next 5Y37.8%
FCF growth 1Y20.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.78%
OCF growth 3YN/A
OCF growth 5YN/A